Learn more about Peter Attia’s digital program
#289 – AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more
“There has been a pretty clear and consistent benefit [to cancer screening] that has been demonstrated, and the exceptions I think have a pretty clear sense of why.” —Peter Attia
More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope
#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.
“Early detection is going to allow our same toolbox of drugs to be massively more effective.” —Keith Flaherty
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
“I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn
Are “safe” levels of air pollution really safe?
Current evidence, and what to do about it
A broader perspective on lung cancer
Not just a “smoker’s disease”